Dose-escalation study of a second-generation non-ansamycin...

Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour

Wagner, Andrew J., Agulnik, Mark, Heinrich, Michael C., Mahadevan, Daruka, Riedel, Richard F., von Mehren, Margaret, Trent, Jonathan, Demetri, George D., Corless, Christopher L., Yule, Murray, Lyons,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.03.076
Date:
July, 2016
File:
PDF, 634 KB
english, 2016
Conversion to is in progress
Conversion to is failed